Analysis Life Sciences Thank You What We Expect the FDA to do in October 2023
Agency IQ
SEPTEMBER 29, 2023
The proposed rule will identify certain bulk drug substances that FDA has considered and is proposing to place on the 503A Bulks List and certain bulk drug substances that FDA has considered and is proposing not to include on the 503A Bulks List. The final rule will amend the administrative destruction provisions in 21 CFR 1.94
Let's personalize your content